对 pT3N0M0食道癌进行手术的辅助治疗模式
Su Pei1, Jiang-Qiong Huang1, Huan-Wei Liang1
1Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
概括
辅助治疗没有改善食道状细胞癌患者手术后的生存率. 然而,化学放射治疗和化疗改善了食道腺癌患者的整体存活率.
科学领域:
- 在瘤学瘤学.
- 手术瘤学手术瘤学
- 胃肠病学 胃肠病学
背景情况:
- 食道癌的分期对于治疗决策至关重要.
- 对于pT3N0M0食道癌的手术后辅助疗法需要进一步调查.
- 新辅助化学放射治疗没有给研究队列.
研究的目的:
- 评估辅助治疗模式对患有 pT3N0M0食道癌后食道切除术的患者生存的影响.
- 为了比较单独的手术和各种辅助治疗方式之间的整体存活率 (OS).
- 根据食道癌组织学来确定辅助疗法的差异效应.
主要方法:
- 在2000年至2020年期间,对445名被诊断为pT3N0M0食道癌的患者进行了回顾性分析.
- 来自监测,流行病学和最终结果 (SEER) 数据库的数据.
- 卡普兰-梅尔分析被用来比较不同治疗组的整体存活期 (OS).
主要成果:
- 对于状细胞癌,辅助化疗或放射治疗,化疗或放射治疗,与单独手术相比,在 OS 上没有显著差异.
- 对于腺癌,辅助化学放射治疗 (HR=0.51,P<0.001) 和化疗 (HR=0.61,P=0.006) 与单独手术相比,显著改善了OS.
- 在腺癌患者中,辅助放射治疗没有显著改变OS (HR=0.81,P=0.495).
结论:
- 辅助疗法不能提高pT3N0M0食道状细胞癌患者的生存结果接受手术.
- 建议使用辅助化学放射治疗和化疗,以改善 pT3N0M0食道腺癌患者手术后的生存率.
- 组织学亚型是确定食道癌辅助治疗疗效的关键因素.
相关概念视频
Barrett Esophagus-II: Clinical Manifestations and Management
141
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
141
Peptic Ulcer Disease V: Surgical Management and Nursing Care
302
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
302
Esophageal Perforation-II: Clinical Manifestations and Management
59
Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
Clinical Manifestations:
59
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
127
Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
127


